IFITM1 and endometrioid stromal sarcoma: According to Busca et al. [19], IFITM1 and CD10 were expressed in 14 ESS cases, and although their sensitivities were 83 and 91%, respectively, IFITM1 showed a higher specificity than CD10, that is, 70% vs 45%.